Uncategorised - European Medical Journal

Analysis of Skeleton Reveals Fresh Insights into Bone Diseases

New insights into the genetics of a range of bone diseases have been revealed following the DNA analysis of unusual skeletal remains of a fetus…

Innovative Brain Scanner Enables Measurement of Activity During Movement

An innovative scanner that enables brain activity to be measured during natural movements has been developed by researchers from the University of…

Screening for Prostate Cancer: CAP Trial Findings

New insights into screening for prostate cancer have been uncovered as a result of the Cluster Randomised Trial of PSA Testing for Prostate Cancer (CAP)…

Advances in Prostate Cancer Diagnosis: Validated Cut-Off Value

Distinguishing healthy tissues from cancerous tissues in prostate cancer patients with a high degree of specificity and sensitivity has been shown to be…

Novel Scanning Technology Reducing the Need for Liver Biopsy

LIVERMULTISCAN™, Perspectum Diagnostics, Ltd., Oxford, UK, was evaluated in a collaborative study by multiple UK Universities to assess the feasibility…

A Low-Carb Solution for Fatty Liver Disease

A carbohydrate-restricted diet has long been championed as an effective weight loss tool, but new research from the KTH Royal Institute of Technology…

An Interview with Karsten Kissel, Head Global Medical Affairs Biosimilars, Boehringer Ingelheim

What attracted me to the pharma industry was the opportunity to shape the development and implementation of treatments on a much broader scale than I…

Synthetic Enzymes Can Deliver Drugs in Cells

Drugs could be activated in biological environments such as living cells by Single-Chain Polymeric Nanoparticles (SCPN) mimicking enzymes, according to…

Crucial New Insights into How a Protein Antibiotic Eliminates a Hospital Bacterium

Development of new forms of antibiotics to combat various bacterial infections could be on the horizon following a study uncovering the ways in which a…

Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer Patients in Europe

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, today announces that its next-generation sequencing (NGS)-based…